Veteran growth-stage investor and operator concentrating on technology and consumer sectors, Jeff Kautz leverages cross-border deal experience and operational leadership to source and scale high-growth companies. He combines prior operating roles with private equity and venture investing, focusing on revenue acceleration, commercial strategy, and board governance. Market-facing profile emphasizes hands-on portfolio support, follow-on capital coordination and exit readiness for institutional LPs and strategic acquirers.
Veteran growth-stage investor and operator concentrating on technology and consumer sectors, Jeff Kautz leverages cross-border deal experience and operational leadership to source and scale high-growth companies. He combines prior operating roles with private equity and venture investing, focusing on revenue acceleration, commercial strategy, and board governance. Market-facing profile emphasizes hands-on portfolio support, follow-on capital coordination and exit readiness for institutional LPs and strategic acquirers.
Focuses on growth-stage technology and consumer opportunities, deploying capital and operational leadership to accelerate revenue, commercial go-to-market and unit economics. Prefers concentrated, hands-on investments with board-level governance, milestone-based follow-on funding and cross-border exit pathways. Underwrites deals for scalable repeatability, prioritizing companies with clear distribution leverage, measurable KPIs and path-to-profitability over a multi-year scaling horizon.
Focuses on growth-stage technology and consumer opportunities, deploying capital and operational leadership to accelerate revenue, commercial go-to-market and unit economics. Prefers concentrated, hands-on investments with board-level governance, milestone-based follow-on funding and cross-border exit pathways. Underwrites deals for scalable repeatability, prioritizing companies with clear distribution leverage, measurable KPIs and path-to-profitability over a multi-year scaling horizon.
| Trades 632 | Longs Won 325/632 51% | Profit Factor 1.34 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $166,537.44 |
| Average Win $74,611.58 | Best Trade (Mar 30) $1.39M | Sharpe Ratio -14.47 |
| Average Loss -$58,903.38 | Worst Trade (Sep 29) -$1.12M | Z-Score 0.06 (4.81%) |
| Commissions $0 | Avg. Trade Length 1y 4m 2w 4d | Expectancy $9,888.72 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.41% |
| Consecutive Losing Trades | 1,250 | 1,125 | 1,000 | 875 | 750 | 625 | 500 | 375 | 250 | 125 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ABM ABM Industries Inc. | 21,252 | $953,405.66 | $1.08M | - | $127,683.58 | 13.39% | +0.454% |
ADUS Addus HomeCare Corporation | 7,396 | $687,242.91 | $864,062.85 | - | $176,819.94 | 25.73% | +0.179% |
AEIS Advanced Energy Industries Inc. | 4,027 | $437,609.65 | $982,869.89 | - | $545,260.24 | 124.6% | -6.404% |
ALG Alamo Group Inc. | 5,156 | $1.08M | $786,109.54 | - | -$297,853.61 | -27.48% | -0.732% |
ASTH Astrana Health Inc. | 29,786 | $1.14M | $1.16M | - | $17,628.3 | 1.55% | +2.931% |
ATEN A10 Networks, Inc. | 43,965 | $797,964.85 | $1.11M | - | $313,470.35 | 39.28% | -6.543% |
AWR American States Water Co. | 10,039 | $807,117.51 | $834,090.31 | - | $26,972.8 | 3.34% | +0.77% |
BAH Booz Allen Hamilton Holding Corporation | 2,949 | $360,218.41 | $215,527.66 | - | -$144,690.75 | -40.17% | +1.691% |
BR Broadridge Financial Solutions, Inc. | 1,283 | $264,079.19 | $223,113.7 | - | -$40,965.49 | -15.51% | +3.352% |
BRC Brady Corporation | 18,876 | $1.11M | $1.58M | - | $470,497.5 | 42.39% | +0.084% |
BRKR Bruker Corporation | 18,063 | $744,195.93 | $1.02M | - | $271,847.82 | 36.53% | +1.169% |
CBT Cabot Corporation | 10,831 | $812,326.05 | $817,957.12 | - | $5,631.07 | 0.69% | +0.492% |
CF CF Industries Holdings, Inc. | 3,192 | $255,333.64 | $379,464.96 | - | $124,131.32 | 48.62% | -0.486% |
CGNX Cognex Corporation | 18,944 | $679,331.99 | $1.05M | - | $370,165.61 | 54.49% | -3.265% |
CHD Church & Dwight Co., Inc. | 2,849 | $238,889 | $291,623.64 | - | $52,734.64 | 22.07% | -0.263% |
CHE Chemed Corporation | 2,192 | $981,445.96 | $1.13M | - | $147,751.88 | 15.05% | +0.383% |
CNS Cohen & Steers Inc. | 13,074 | $991,980.32 | $888,214.87 | - | -$103,765.45 | -10.46% | +2.331% |
CPAY Corpay, Inc. | 843 | $259,854.75 | $339,134.68 | - | $79,279.93 | 30.51% | +2.36% |
CPRT Copart Inc. | 6,758 | $264,576 | $186,892.49 | - | -$77,683.51 | -29.36% | +5.272% |
CPRX Catalyst Pharmaceuticals Inc. | 36,010 | $557,996.93 | $1.13M | - | $575,957.97 | 103.22% | 0.0 |